Data / Form D filings / CESSATION THERAPEUTICS, INC.
CESSATION THERAPEUTICS, INC.: Form D filings
CESSATION THERAPEUTICS, INC., a biotechnology company in Dallas, TX, filed 2 Form D notices with the SEC between 2022 and 2024. The latest, on April 3, 2024, reports $1 million sold of a $1 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12200 Stemmons Freeway, Suite 100, Dallas, TX, 75234
- Phone
- (408) 479-7843
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1926434
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 3, 2024 | New notice | $1,000,000 | $1,000,000 | 2 | Mar 29, 2024 | sec.gov | |
| May 11, 2022 | New notice | $10,000,000 | $5,755,000 | $4,245,000 | 31 | May 2, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew Barrett | Executive Officer | |
| Sharon Tetlow | Director | |
| John Harkey | Director | |
| Daniel Fine | Director | |
| Jay Shepard | Director | |
| Mark Pearson | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Apr 1, 2024 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CESSATION THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.